Project Grant R44EY036772
- This federal Project Grant award of $315,825.00 from the National Eye Institute (CFDA 93.867 Vision Research) supports the development of a new, non-invasive, remote photonic technology for intraocular pressure (IOP) biomonitoring in glaucoma patients. The technology, called Photonic IOP Biomonitoring (PIB), uses sound waves and laser speckle pattern monitoring to deduce IOP without the need for physical eye contact or clinician interpretation. The goal is to miniaturize PIB into monoculars or...
- This is a Cooperative Agreement award from the National Eye Institute (NEI), part of the U.S. Department of Health and Human Services, under the Vision Research federal grant program (CFDA 93.867). The $791,994 award, which began on September 1, 2025, supports the development of a next-generation ophthalmic microscope with integrated optical coherence tomography (OCT) imaging capabilities. The project aims to overcome limitations of current ophthalmic surgery microscopes by enabling more...
- This federal Project Grant award of $598,108 from the National Eye Institute (CFDA 93.867 Vision Research) supports the development of innovative ophthalmic imaging technologies and novel objective, quantifiable functional biomarkers for cone photoreceptors. The primary aims are to: 1) Develop next-generation optical coherence tomography (OCT) technologies to enable functional photoreceptor imaging over a wide retinal area and at high topographical resolution; and 2) Develop novel objective,...
- The National Eye Institute (NEI) awarded Kineolabs, Inc. a $300,001 Project Grant under the Vision Research program (CFDA 93.867) to develop a portable, low-cost line-scan swept-source optical coherence tomography (LS-SS-OCT) imaging system. The objective is to use this LS-SS-OCT technology for early detection and monitoring of age-related macular degeneration (AMD), diabetic retinopathy, and other eye diseases. The project aims to make OCT imaging more affordable and accessible to reduce the...
- The Project Grant award from the National Eye Institute (CFDA 93.867 Vision Research) supports the development of an accurate, non-invasive, and automated 24-hour intraocular pressure (IOP) monitoring device. The overarching goal is to create a wearable IOP monitor that can improve the clinical management of glaucoma, the leading cause of irreversible blindness. The $713,964 award will fund research activities over a 5-year period from March 2025 to February 2030 at the University of California,...
- This $237,996 Project Grant from the National Eye Institute (CFDA 93.867 Vision Research program) aims to investigate advanced approaches for high-resolution in-vivo imaging of the cornea. The award to the University of Colorado will develop a speckle illumination holographic imaging technique that can capture wide field-of-view, 3D information about corneal structures with polarization-sensitive detection. After optimization, the system will be validated through in-vivo testing in healthy human...
- This Project Grant award of $375,940 from the National Eye Institute (NEI) under the Vision Research federal grant program (CFDA 93.867) aims to conduct a feasibility study for using the NeuroVEP system developed by Neurofieldz Inc. to provide objective diagnostic information on neuro-ophthalmic diseases affecting the afferent visual system. The key products or services to be delivered under this Phase I Small Business Innovation Research (SBIR) project include: 1) Developing custom tests for...
- The National Eye Institute (NEI) awarded a Project Grant of $305,853 to Bluebird Photonics, Inc. under the Vision Research federal grant program (CFDA 93.867) to develop a novel light source for robust multi-MHz retinal optical coherence tomography (OCT). The project aims to enable next-generation OCT technology that can provide diagnostic screening and visualization of both the central and peripheral retinal areas through a roughly 50-fold increase in imaging speed. This advancement is...
- This SBIR Phase I Project Grant, awarded by the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (CFDA 47.084) program, provides $304,998 to support the development of a novel visible-light phase shifter and intraocular lens to improve vision for those with age-related macular degeneration. The project aims to create an energy-efficient, small-form factor optical phased array in an implantable intraocular device capable of electronically adjusting and shifting...
- This Project Grant award from the National Eye Institute (CFDA 93.867 - Vision Research) aims to develop and validate a novel Adaptive Optics Optical Coherence Tomography (AO-OCT) system tailored for high-resolution, wide-field retinal imaging in small animal models, specifically mice. The $305,000 project, awarded on September 1, 2025, with an expected completion date of August 31, 2026, has two key objectives: Develop and optimize a portable AO-OCT system with enhanced imaging capabilities...
This Project Grant award from the National Eye Institute (CFDA 93.867 - Vision Research) provides $566,288 to Intelon Optics, Inc. to develop a next-generation Brillouin Optical Scanner System (BOSS) with improved speed, accuracy, and sensitivity compared to the current commercial-grade product. The objective is to translate the University of Maryland's Brillouin research technology into a novel BOSS device that can clearly differentiate mild-to-moderate keratoconus and subclinical keratoconus from normal corneas, unlocking the potential of Brillouin technology for multiple ophthalmology applications such as corneal ectasia, corneal and cataract surgeries, myopia, and glaucoma. The project will run from September 15, 2025 to August 31, 2027.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $566.3k | 9/11/25 |